Loading patent…
AssigneeNovartis AG
InventorsYuichiro ADACHI, John Louis DIENER, Robert J. A. FROST, Yan-Ling HE, Venkateswar JARUGULA, Adel R. RIZKALA, Cesare RUSSO, Xueping WU
Estimating the term…
Described herein are methods of using an anti-natriuretic peptide receptor 1 (NPR1) antibody or antigen binding fragment thereof for the treatment or prevention of a disease or disorder in a human, in particular for a disorder or a disease associated with natriuretic peptide receptor activity (including, but not limited to heart failure, e.g., HFrEF, HFmrEF, or HFpEF; or hypertension, e.g., resistant hypertension).
A method of treating a disorder or a disease associated with natriuretic peptide receptor 1 (NPR1) activity in a subject in need thereof, the method comprising administering to the subject about 10 mg to about 700 mg of an anti-NPR1 antibody or antigen binding fragment thereof.
-6. (canceled)
-9. (canceled)
-15. (canceled)
-52. (canceled)
Dependencies are inferred from the claim text.